Overview

Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
0
Participant gender:
Female
Summary
This study is a regulatory post-marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Julina for postmenopausal osteoporosis. The objective of this study is to assess safety and efficacy of using Julina in clinical practice. A total 100 patients will be recruited and followed 3 years since starting Julina administration.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Bayer
Criteria
Inclusion Criteria:

- Patients who received Julina for postmenopausal osteoporosis

Exclusion Criteria:

- Patients who are contraindicated based on the product label